课题基金 / 基金详情

Analysis of Immunological Tolerance to a nuclear autoantigen using transgenic mcie.

Analysis of Immunological Tolerance to a nuclear autoantigen using transgenic mcie.
使用转基因 mcie 分析对核自身抗原的免疫耐受性。
批准号:
11670441
负责人:
MISAKI Yoshikata
金额:
$2.3万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1999
资助国家:
日本
项目状态:
已结题
起止时间:
1999 至 2000

项目摘要

项目成果

MISAKI Yoshikata的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
It remains unknown why the T cell tolerance to nuclear autoantigens is impaired in systemic autoimmune diseases. To clarify this, we generated transgenic mice expressing OVA mainly in the nuclei (Ld-nOVA mice). When CD4^+ T cells from DO11.10 mice expressing a TCR specific for OVA_<323-339> were transferred into Ld-nOVA mice, they were rendered anergic but persisted in vivo for at least three months. These cells expressed CD44^<high>, CD45RB^<low> and were generated after multiple cell divisions, suggesting that anergy is not the result of insufficient proliferative stimuli. Whereas dendritic cells (DCs) from Ld-nOVA (TgDCs) efficiently induced proliferation of DO11.10 T cells, divided T cells stimulated by TgDCs in vivo exhibited a lower memory response than T cells stimulated by peptide-pulsed DCs. Furthermore, repeated transfer of TgDCs induced hyporesponsiveness of DO11.10 T cells in antigen-free wild-type recipients, suggesting that the repeated encounters with TgDCs rendered DO11.10 T cells persistent anergy. Since the state of TgDCs and peptide-pulsed DCs was almost the same except for the expression level of the agonistic ligand, the property of nuclear autoantigens which controls the tolerance of CD4^+ T cells might be the low and continuous expression of a self-peptide on DCs.
期刊论文(19)
专著(0)
科研奖励(0)
会议论文
三崎義堅,瀬戸口京吾 他: "IL-10遺伝子導入抗原特異的T細胞を用いた実験的関節炎の治療"日本臨床免疫学会誌. 23. 538-541 (2000)
Yoshikata Misaki、Kyogo Setoguchi 等:“使用 IL-10 基因转移的抗原特异性 T 细胞治疗实验性关节炎”日本临床免疫学会杂志 23. 538-541 (2000)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Y Misaki,I Ezaki et al.: "Gene-transferred oligoclonal T cells predominantly persist in peripheral blood from an adenosine deaminase deficient patient during gene therapy."Molecular Therapy. 3. 24-27 (2001)
Y Misaki,I Ezaki 等人:“在基因治疗期间,基因转移的寡克隆 T 细胞主要存在于腺苷脱氨酶缺陷患者的外周血中。”分子治疗。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
M Miyamasu,Y Misaki et al.: "Regulation of human eotaxin generation by Th1-/Th2-derived cytokines."Int Arch Allergy Immunol.. 122. 54-58 (2000)
M Miyamasu、Y Misaki 等人:“Th1-/Th2 衍生细胞因子对人嗜酸细胞趋化因子生成的调节”。Int Arch Allergy Immunol.. 122. 54-58 (2000)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Fujio K, Misaki Y, Setoguchi K, Morita S, Kawahata K, Kato I, Nosaka T, Yamamoto K, Kitamura T.: "Functional reconstituion of class II restricted T cell immunity mediated by retroviral transfer of α/β T cell receptor complex."J Immunol.. 165(1). 528-32 (2
Fujio K、Misaki Y、Setoguchi K、Morita S、Kawahata K、Kato I、Nosaka T、Yamamoto K、Kitamura T.:“通过 α/β T 细胞受体复合物逆转录病毒转移介导的 II 类限制性 T 细胞免疫的功能重建.“免疫学杂志.. 165(1). 528-32 (2
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
16
    The development of an innovative therapy for autoimmune diseases by controlling FOXP3, a unique transcription factors of the regulatory T cells
    • 批准号:
      17591032
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.37万
    • 财政年份:
      2005
    • 负责人:
      MISAKI Yoshikata
    • 依托单位:
    The development of Autoimmune-diseases antigen-specific therapy by the induction of regulatory T cells transcription factors
    • 批准号:
      13670450
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.3万
    • 财政年份:
      2001
    • 负责人:
      MISAKI Yoshikata
    • 依托单位: